Virscio Email Format
Biotechnology ResearchConnecticut, United States51-200 Employees
Virscio is a mid-sized biotechnology research firm based in New Haven, Connecticut. It provides translational research services focused on in vivo safety and disease modeling in nonhuman primates, along with related preclinical development and histopathology across species. The company concentrates on central nervous system, ophthalmology, cardiovascular, metabolic, and dermatologic diseases, backed by advanced preclinical toxicology and efficacy programs for sponsors worldwide. Virscio collaborates with pharmaceutical and biotechnology companies, as well as consultants and academic teams, to reduce development risk and identify the most effective path to clinic. In August 2023, the company announced the appointment of Sven Korte, Ph.D., as Senior Director of Research and Safety Assessment.